Unternehmen
Abbott Laboratories

Aktueller Kurs
111.3 USD

Symbol
ABT

ISIN
US0028241000

Börse
NYSE

Sektor
Health Care

Marktkapitalisierung
197.264 Mrd. US

Branche
Health Care Equipment & Supplies

Dividendenrendite
1.62 %

Ausschüttungsquote
48.57 %

KGV
58.86

KUV (TTM)
6.14

KGVe
25.19

Kursziel
121.76 USD

Unternehmen
Abbott Laboratories

Aktueller Kurs
111.3 USD

Symbol
ABT

ISIN
US0028241000

Börse
NYSE

Marktkapitalisierung
197.264 Mrd. USD

Sektor
Health Care

Branche
Health Care Equipment & Supplies

Dividendenrendite
1.62 %

Ausschüttungsquote
48.57 %

KGV
58.86

KUV (TTM)
6.14

KGVe
25.19

Kursziel
121.76 USD

Live-Chart (verzögert)

Firmenbeschreibung

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.

Abbott Laboratories Fundamentaldaten

Jahre und Quartale beziehen sich jeweils auf das Geschäftsjahr des Unternehmens. (Das Geschäftsjahr kann ggf. vom Kalenderjahr abweichen.)

Das Geschäftsjahr von Abbott Laboratories endet im Dezember.

Gewinn pro Jahr & Quartal (Net Income) in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 0.564 0.537 1.232 0.000 2.333
2019 0.672 1.006 0.960 1.049 3.687
2018 0.418 0.733 0.563 0.654 2.368
2017 0.419 0.283 0.603 -0.828 0.477
2016 0.316 0.615 -0.329 0.798 1.400
2015 2.292 0.784 0.580 0.767 4.423
2014 0.375 0.466 0.538 0.905 2.284
2013 0.545 0.476 0.773 0.782 2.576
2012 1.242 1.725 1.943 1.053 5.963
2011 0.864 1.943 0.303 1.619 4.728
2010 1.003 1.292 0.891 1.441 4.626

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 0.65 0.57 0.98 0 2.2
2019 0.63 0.82 0.84 0.95 3.24
2018 0.59 0.73 0.75 0.81 2.88
2017 0.48 0.62 0.66 0.74 2.5
2016 0.41 0.55 0.59 0.65 2.2
2015 0.47 0.52 0.54 0.62 2.15
2014 0.41 0.54 0.62 0.71 2.28
2013 0.42 0.46 0.55 0.58 2.01
2012 1.03 1.23 1.3 1.51 5.07
2011 0.91 1.12 1.18 1.45 4.66
2010 0.81 1.01 1.05 1.3 4.17

Umsatz pro Jahr & Quartal in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 7.726 7.328 8.853 0 23.907
2019 7.535 7.979 8.076 8.314 31.904
2018 7.39 7.767 7.656 7.765 30.578
2017 6.335 6.637 6.829 7.589 27.39
2016 4.885 5.333 5.302 5.333 20.853
2015 6.634 5.17 5.15 3.451 20.405
2014 5.244 5.551 5.104 4.348 20.247
2013 5.37789 5.44602 5.56201 5.46207 21.848
2012 9.45663 9.8071 9.77324 10.8369 39.8739
2011 9.04085 9.61629 9.81666 10.3775 38.8513
2010 7.69835 8.82601 8.67451 9.96785 35.1667

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 4.34 4.11 4.95 0.00 37.01
2019 4.24 4.48 4.53 4.67 17.91
2018 4.19 4.39 4.32 4.39 17.28
2017 3.65 3.79 3.89 4.34 15.66
2016 3.29 3.60 3.59 3.60 14.06
2015 4.38 3.44 3.42 2.29 13.55
2014 3.39 3.66 3.36 2.85 13.26
2013 3.39 3.45 3.55 3.47 13.88
2012 5.95 6.17 6.13 6.81 25.05
2011 5.80 6.14 6.26 6.58 24.64
2010 4.93 5.69 5.58 6.41 22.60

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 -46.23 -4.79 129.42 -100.00 -36.72
2019 2.75 49.70 -4.57 9.27 55.70
2018 0.00 75.36 -23.19 16.16 396.44
2017 -47.49 -32.46 113.07 -237.31 -65.93
2016 -58.80 94.62 -153.50 0.00 -68.35
2015 153.26 -65.79 -26.02 32.24 93.65
2014 -52.07 24.27 15.45 68.22 -11.35
2013 -48.29 -12.54 62.25 1.24 -56.79
2012 -23.26 38.84 12.65 -45.78 26.11
2011 -40.05 124.91 -84.39 433.89 2.21
2010 -34.82 28.78 -31.04 61.77 -19.49

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 -7.07 -5.15 20.81 0.00 0.00
2019 -2.96 5.89 1.22 2.95 4.34
2018 -2.62 5.10 -1.43 1.42 11.64
2017 18.79 4.77 2.89 11.13 31.35
2016 41.55 9.17 -0.58 0.58 2.20
2015 52.58 -22.07 -0.39 -32.99 0.78
2014 -3.99 5.85 -8.05 -14.81 -7.33
2013 -50.37 1.27 2.13 -1.80 -45.21
2012 -8.87 3.71 -0.35 10.88 2.63
2011 -9.30 6.36 2.08 5.71 10.48
2010 -12.42 14.65 -1.72 14.91 14.31

Abbott Laboratories Fundamentaldaten

Gewinn pro Jahr & Quartal (Net Income)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 0.564 0.537 1.232 0.000 2.333
2019 0.672 1.006 0.960 1.049 3.687
2018 0.418 0.733 0.563 0.654 2.368
2017 0.419 0.283 0.603 -0.828 0.477
2016 0.316 0.615 -0.329 0.798 1.400
2015 2.292 0.784 0.580 0.767 4.423
2014 0.375 0.466 0.538 0.905 2.284
2013 0.545 0.476 0.773 0.782 2.576
2012 1.242 1.725 1.943 1.053 5.963
2011 0.864 1.943 0.303 1.619 4.728
2010 1.003 1.292 0.891 1.441 4.626

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 0.65 0.57 0.98 0 2.2
2019 0.63 0.82 0.84 0.95 3.24
2018 0.59 0.73 0.75 0.81 2.88
2017 0.48 0.62 0.66 0.74 2.5
2016 0.41 0.55 0.59 0.65 2.2
2015 0.47 0.52 0.54 0.62 2.15
2014 0.41 0.54 0.62 0.71 2.28
2013 0.42 0.46 0.55 0.58 2.01
2012 1.03 1.23 1.3 1.51 5.07
2011 0.91 1.12 1.18 1.45 4.66
2010 0.81 1.01 1.05 1.3 4.17

Umsatz pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 7.726 7.328 8.853 0 23.907
2019 7.535 7.979 8.076 8.314 31.904
2018 7.39 7.767 7.656 7.765 30.578
2017 6.335 6.637 6.829 7.589 27.39
2016 4.885 5.333 5.302 5.333 20.853
2015 6.634 5.17 5.15 3.451 20.405
2014 5.244 5.551 5.104 4.348 20.247
2013 5.37789 5.44602 5.56201 5.46207 21.848
2012 9.45663 9.8071 9.77324 10.8369 39.8739
2011 9.04085 9.61629 9.81666 10.3775 38.8513
2010 7.69835 8.82601 8.67451 9.96785 35.1667

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 4.34 4.11 4.95 0.00 37.01
2019 4.24 4.48 4.53 4.67 17.91
2018 4.19 4.39 4.32 4.39 17.28
2017 3.65 3.79 3.89 4.34 15.66
2016 3.29 3.60 3.59 3.60 14.06
2015 4.38 3.44 3.42 2.29 13.55
2014 3.39 3.66 3.36 2.85 13.26
2013 3.39 3.45 3.55 3.47 13.88
2012 5.95 6.17 6.13 6.81 25.05
2011 5.80 6.14 6.26 6.58 24.64
2010 4.93 5.69 5.58 6.41 22.60

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 -46.23 -4.79 129.42 -100.00 -36.72
2019 2.75 49.70 -4.57 9.27 55.70
2018 0.00 75.36 -23.19 16.16 396.44
2017 -47.49 -32.46 113.07 -237.31 -65.93
2016 -58.80 94.62 -153.50 0.00 -68.35
2015 153.26 -65.79 -26.02 32.24 93.65
2014 -52.07 24.27 15.45 68.22 -11.35
2013 -48.29 -12.54 62.25 1.24 -56.79
2012 -23.26 38.84 12.65 -45.78 26.11
2011 -40.05 124.91 -84.39 433.89 2.21
2010 -34.82 28.78 -31.04 61.77 -19.49

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 -7.07 -5.15 20.81 0.00 0.00
2019 -2.96 5.89 1.22 2.95 4.34
2018 -2.62 5.10 -1.43 1.42 11.64
2017 18.79 4.77 2.89 11.13 31.35
2016 41.55 9.17 -0.58 0.58 2.20
2015 52.58 -22.07 -0.39 -32.99 0.78
2014 -3.99 5.85 -8.05 -14.81 -7.33
2013 -50.37 1.27 2.13 -1.80 -45.21
2012 -8.87 3.71 -0.35 10.88 2.63
2011 -9.30 6.36 2.08 5.71 10.48
2010 -12.42 14.65 -1.72 14.91 14.31

Abbott Laboratories Dividenden-Entwicklung

Ex-Tag Record Date Zahltag Dividende
2021-01-14 2021-01-15 2021-02-16 0.45
2020-10-14 2020-10-15 2020-11-16 0.36
2020-07-14 2020-07-15 2020-08-17 0.36
2020-04-14 2020-04-15 2020-05-15 0.36
2020-01-14 2020-01-15 2020-02-14 0.36
2019-10-11 2019-10-15 2019-11-15 0.32
2019-07-12 2019-07-15 2019-08-15 0.32
2019-04-12 2019-04-15 2019-05-15 0.32
2019-01-14 2019-01-15 2019-02-15 0.32
2018-10-12 2018-10-15 2018-11-15 0.28
2018-07-12 2018-07-13 2018-08-15 0.28
2018-04-12 2018-04-13 2018-05-15 0.28
2018-01-11 2018-01-12 2018-02-15 0.28
2017-10-12 2017-10-13 2017-11-15 0.265
2017-07-12 2017-07-14 2017-08-15 0.265
2017-04-11 2017-04-14 2017-05-15 0.265
2017-01-11 2017-01-13 2017-02-15 0.265
2016-10-12 2016-10-14 2016-11-15 0.26
2016-07-13 2016-07-15 2016-08-15 0.26
2016-04-13 2016-04-15 2016-05-16 0.26